2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Anti-Parkinson Drugs Market?

The increasing geriatric population and the rise in Parkinson’s disease (PD) cases are significant factors contributing to the growth of the anti-Parkinson drugs market. PD is most commonly diagnosed in individuals over the age of 60, and with the global aging population, the demand for treatments is expected to escalate. For instance, the World Health Organization projects that by 2030, 1 in 6 people will be 60 years or older, and by 2050, this number will double to 2.1 billion. This surge in the elderly population will likely drive the demand for anti-Parkinson drugs.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3462&type=smp

#What Growth Opportunities Will Drive the Anti-Parkinson Drugs Market’s CAGR Through 2034?

The anti-parkinson drugs market has grown steadily and strongly. It is projected to expand from $10.37 billion in 2024 to $11.08 billion in 2025, reflecting a CAGR of 6.9%. Key factors behind this growth include an aging population, rising incidence of Parkinson’s disease, healthcare infrastructure development, and research advancements.

The anti-Parkinson’s drugs market is expected to experience strong growth, reaching $13.73 billion by 2029 at a CAGR of 5.5%. Growth will be driven by increased awareness, biotechnological advancements, and emerging markets. Key trends include R&D investment, personalized medicine, disease-modifying therapies, drug repurposing, telemedicine, remote monitoring, biosimilars, and research collaborations.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3462

What Are the Most Significant Market Trends Transforming theAnti-Parkinson Drugs Market?

In the anti-Parkinson drugs market, companies are introducing advanced therapeutic options to better manage motor fluctuations and dyskinesia in patients. For instance, in January 2024, AbbVie Inc. launched PRODUODOPA (foslevodopa/foscarbidopa), a 24-hour subcutaneous infusion therapy designed to improve symptoms in patients with advanced Parkinson’s disease who experience severe motor complications.

What Are the Top Market Players Propelling the Growth of theAnti-Parkinson Drugs Industry?

Major companies operating in the anti-parkinson drugs market include GlaxoSmithKline plc, Pfizer Inc., Merck Co., Novartis AG, F. Hoffmann-La Roche AG, UCB S.A, Teva Pharmaceutical Industries Ltd., AbbVie Inc., Mylan NV, C.H. Boehringer Sohn AG & Co. KG, Orion Pharma Ltd., ACADIA Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., Reddy’s Laboratories Ltd., Intas Pharmaceuticals Ltd., US WorldMeds LLC, Zydus Lifesciences Limited, Chemical Industrial & Pharmaceutical Laboratories Ltd., Strides Shasun Ltd., Axcan Pharma Inc., Upsher-Smith Laboratories LLC, H. Lundbeck A/S, Vertical Pharmaceuticals LLC, Zambon SPA, M Somerset Pharmaceuticals Inc., Valeant Pharmaceuticals International Inc., Neurocrine Biosciences Inc., Supernus Pharmaceuticals Inc.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/anti-parkinson-drugs-global-market-report

Which Primary Segments of the Anti-Parkinson Drugs Market Are Driving Growth and Industry Transformations?

The anti-parkinson drugs market covered in this report is segmented –

1) By Drugs Class: Levodopa Or Carbidopa, Dopamine Receptor Agonists, Monoamine Oxidase Type B (MAO-B) Inhibitors, Catechol-O-Methyltransferase (COMT)-inhibitors, Anticholinergics, Other Drugs

2) By Route of Administration: Oral, Injection, Transdermal

3) By Distribution Channel: Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies

Subsegments:

1) By Levodopa Or Carbidopa: Immediate-Release Levodopa Or Carbidopa, Extended-Release Levodopa Or Carbidopa

2) By Dopamine Receptor Agonists: Pramipexole, Ropinirole, Rotigotine

3) By Monoamine Oxidase Type B (MAO-B) Inhibitors: Selegiline, Rasagiline, Safinamide

4) By Catechol-O-Methyltransferase (COMT)-Inhibitors: Entacapone, Tolcapone

5) By Anticholinergics: Benztropine, Trihexyphenidyl

6) By Other Drugs: Amantadine, Apomorphine

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=3462&type=smp

Which Regions Are Key Players in the Growth of the #What Major Innovations Are Driving the Accelerated Growth of the Anti-Parkinson Drugs Market?# Market?

North America was the largest region in the anti-Parkinson drugs market in 2023. Middle East is expected to be the fastest-growing region in the anti-parkinson drugs market during the forecast period. The regions covered in the anti-parkinson drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Reports Similar to the Global Anti-Parkinson Drugs Market 2025, By The Business Research Company:

Dermatology Drugs Global Market Report 2022

https://www.thebusinessresearchcompany.com/report/dermatology-drugs-global-market-report

Electrophysiology Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/electrophysiology-devices-and-equipment-global-market-report

Brain Monitoring Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/brain-monitoring-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: